293 related articles for article (PubMed ID: 3929747)
1. The laboratory heterogeneity of lupus anticoagulants.
Triplett DA; Brandt JT; Maas RL
Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747
[TBL] [Abstract][Full Text] [Related]
2. The laboratory diagnosis of lupus anticoagulants.
Lazarchick J; Kizer J
Arch Pathol Lab Med; 1989 Feb; 113(2):177-80. PubMed ID: 2492798
[TBL] [Abstract][Full Text] [Related]
3. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
4. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants.
Brandt JT; Triplett DA; Musgrave K; Orr C
Arch Pathol Lab Med; 1987 Feb; 111(2):120-4. PubMed ID: 3101649
[TBL] [Abstract][Full Text] [Related]
5. The diagnosis of lupus anticoagulants by the activated partial thromboplastin time--the central role of phosphatidyl serine.
Kelsey PR; Stevenson KJ; Poller L
Thromb Haemost; 1984 Oct; 52(2):172-5. PubMed ID: 6441303
[TBL] [Abstract][Full Text] [Related]
6. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1).
Exner T; Triplett DA; Taberner DA; Howard MA; Harris EN
Thromb Haemost; 1990 Nov; 64(3):478-84. PubMed ID: 2128977
[TBL] [Abstract][Full Text] [Related]
7. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
[TBL] [Abstract][Full Text] [Related]
8. Similar mechanism of various lupus anticoagulants.
Exner T
Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078
[TBL] [Abstract][Full Text] [Related]
9. Assays for lupus anticoagulant: the sensitivity of different assays.
Jain A; Dash S; Marwaha N; Deodhar SD; Sehgal S
Med Lab Sci; 1991 Jan; 48(1):31-5. PubMed ID: 1905773
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of recently described tests for detection of the lupus anticoagulant.
Forastiero RR; Cerrato GS; Carreras LO
Thromb Haemost; 1994 Nov; 72(5):728-33. PubMed ID: 7900080
[TBL] [Abstract][Full Text] [Related]
11. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
Moore GW; Savidge GF
Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
[TBL] [Abstract][Full Text] [Related]
12. Lupus anticoagulant. A report of 8 cases.
Agarwal MB; Agarwal UM
J Assoc Physicians India; 1991 Mar; 39(3):243-5. PubMed ID: 1908857
[TBL] [Abstract][Full Text] [Related]
13. Effect of lupus anticoagulants on the activated partial thromboplastin time. Results of the College of American Pathologists survey program.
Brandt JT; Triplett DA; Rock WA; Bovill EG; Arkin CF
Arch Pathol Lab Med; 1991 Feb; 115(2):109-14. PubMed ID: 1899555
[TBL] [Abstract][Full Text] [Related]
14. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants.
Alving BM; Baldwin PE; Richards RL; Jackson BJ
Thromb Haemost; 1985 Oct; 54(3):709-12. PubMed ID: 3937268
[TBL] [Abstract][Full Text] [Related]
15. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
[TBL] [Abstract][Full Text] [Related]
16. Concurrent lupus anticoagulants and prothrombin deficiency due to phenytoin use.
Harrison RL; Alperin JB; Kumar D
Arch Pathol Lab Med; 1987 Aug; 111(8):719-22. PubMed ID: 3115223
[TBL] [Abstract][Full Text] [Related]
17. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
18. Obstetric complications associated with the lupus anticoagulant.
Branch DW; Scott JR; Kochenour NK; Hershgold E
N Engl J Med; 1985 Nov; 313(21):1322-6. PubMed ID: 3932854
[TBL] [Abstract][Full Text] [Related]
19. Avoiding errors in the laboratory evaluation of potent lupus anticoagulants.
Penmetsa GK; Rodgers GM; Smock KJ
Am J Hematol; 2010 Apr; 85(4):272-4. PubMed ID: 20196174
[No Abstract] [Full Text] [Related]
20. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification.
Triplett DA; Barna LK; Unger GA
Thromb Haemost; 1993 Nov; 70(5):787-93. PubMed ID: 8128436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
